RESUMEN
Magnetic nanoparticle clusters composed of primary magnetic nanoparticles can not only significantly enhance the magnetic properties of the assembly but also retain the superparamagnetic properties of the individual primary nanoparticle, which is of great significance for promoting the development of multifunctional advanced materials. Herein, water-soluble biocompatible and superparamagnetic europium-doped iron oxide nanoparticle clusters (EuIO NCs) were directly synthesized by a simple one-pot method. The obtained EuIO NCs have excellent water solubility, colloidal stability, and biocompatibility. Europium doping significantly improved the contrast enhancement effect of EuIO NCs in T1-weighted MR imaging. In addition, EuIO NCs can be functionalized by active molecules, and the rhodamine123-functionalized EuIO NCs have long circulation time and excellent fluorescence imaging performance in vivo. This study provides a simple strategy for the design and construction of a novel multifunctional magnetic nanoplatform and provides solutions for the development of multimodal imaging probes and the diagnosis of disease.
Asunto(s)
Medios de Contraste/química , Nanopartículas Magnéticas de Óxido de Hierro/química , Animales , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Medios de Contraste/síntesis química , Medios de Contraste/farmacocinética , Medios de Contraste/toxicidad , Europio/química , Europio/farmacocinética , Europio/toxicidad , Colorantes Fluorescentes/química , Hemólisis/efectos de los fármacos , Humanos , Nanopartículas Magnéticas de Óxido de Hierro/toxicidad , Fenómenos Magnéticos , Imagen por Resonancia Magnética/métodos , Ratones Endogámicos BALB C , Ratones Desnudos , Imagen Óptica/métodos , Rodamina 123/química , Solubilidad , Agua/químicaRESUMEN
Background: Delivery of long-acting nanoformulated antiretroviral drugs (ARVs) to human immunodeficiency virus type one cell and tissue reservoirs underlies next generation antiretroviral therapeutics. Nanotheranostics, comprised of trackable nanoparticle adjuncts, can facilitate ARV delivery through real-time drug tracking made possible through bioimaging platforms. Methods: To model HIV-1 therapeutic delivery, europium sulfide (EuS) nanoprobes were developed, characterized and then deployed to cells, tissues, and rodents. Tests were performed with nanoformulated rilpivirine (NRPV), a non-nucleoside reverse transcriptase inhibitor (NNRTI) used clinically to suppress or prevent HIV-1 infection. First, CD4+ T cells and monocyte-derived macrophages were EuS-treated with and without endocytic blockers to identify nanoprobe uptake into cells. Second, Balb/c mice were co-dosed with NRPV and EuS or lutetium177-doped EuS (177LuEuS) theranostic nanoparticles to assess NRPV biodistribution via mass spectrometry. Third, single photon emission computed tomography (SPECT-CT) and magnetic resonance imaging (MRI) bioimaging were used to determine nanotheranostic and NRPV anatomic redistribution over time. Results: EuS nanoprobes and NRPV entered cells through dynamin-dependent pathways. SPECT-CT and MRI identified biodistribution patterns within the reticuloendothelial system for EuS that was coordinate with NRPV trafficking. Conclusions: EuS nanoprobes parallel the uptake and biodistribution of NRPV. These data support their use in modeling NRPV delivery to improve treatment strategies.
Asunto(s)
Fármacos Anti-VIH , Portadores de Fármacos , Europio , Infecciones por VIH , VIH-1/metabolismo , Imagen por Resonancia Magnética , Nanopartículas , Rilpivirina , Tomografía Computarizada por Tomografía Computarizada de Emisión de Fotón Único , Sulfuros , Animales , Fármacos Anti-VIH/química , Fármacos Anti-VIH/farmacocinética , Fármacos Anti-VIH/farmacología , Línea Celular , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/farmacocinética , Preparaciones de Acción Retardada/farmacología , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/farmacología , Europio/química , Europio/farmacocinética , Europio/farmacología , Infecciones por VIH/diagnóstico por imagen , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/metabolismo , Infecciones por VIH/patología , Humanos , Masculino , Ratones , Ratones Endogámicos BALB C , Nanopartículas/química , Nanopartículas/uso terapéutico , Rilpivirina/química , Rilpivirina/farmacocinética , Rilpivirina/farmacología , Sulfuros/química , Sulfuros/farmacocinética , Sulfuros/farmacologíaRESUMEN
RATIONALE: Long-acting slow effective release antiretroviral therapy (LASER ART) was developed to improve patient regimen adherence, prevent new infections, and facilitate drug delivery to human immunodeficiency virus cell and tissue reservoirs. In an effort to facilitate LASER ART development, "multimodal imaging theranostic nanoprobes" were created. These allow combined bioimaging, drug pharmacokinetics and tissue biodistribution tests in animal models. METHODS: Europium (Eu3+)- doped cobalt ferrite (CF) dolutegravir (DTG)- loaded (EuCF-DTG) nanoparticles were synthesized then fully characterized based on their size, shape and stability. These were then used as platforms for nanoformulated drug biodistribution. RESULTS: Folic acid (FA) decoration of EuCF-DTG (FA-EuCF-DTG) nanoparticles facilitated macrophage targeting and sped drug entry across cell barriers. Macrophage uptake was higher for FA-EuCF-DTG than EuCF-DTG nanoparticles with relaxivities of r2 = 546 mM-1s-1 and r2 = 564 mM-1s-1 in saline, and r2 = 850 mM-1s-1 and r2 = 876 mM-1s-1 in cells, respectively. The values were ten or more times higher than what was observed for ultrasmall superparamagnetic iron oxide particles (r2 = 31.15 mM-1s-1 in saline) using identical iron concentrations. Drug particles were detected in macrophage Rab compartments by dual fluorescence labeling. Replicate particles elicited sustained antiretroviral responses. After parenteral injection of FA-EuCF-DTG and EuCF-DTG into rats and rhesus macaques, drug, iron and cobalt levels, measured by LC-MS/MS, magnetic resonance imaging, and ICP-MS were coordinate. CONCLUSION: We posit that these theranostic nanoprobes can assess LASER ART drug delivery and be used as part of a precision nanomedicine therapeutic strategy.
Asunto(s)
Imagen por Resonancia Magnética/métodos , Imagen Multimodal/métodos , Nanomedicina Teranóstica/métodos , Animales , Sistemas de Liberación de Medicamentos/métodos , Europio/química , Europio/farmacocinética , Ácido Fólico/química , Compuestos Heterocíclicos con 3 Anillos/química , Compuestos Heterocíclicos con 3 Anillos/farmacocinética , Macaca mulatta , Macrófagos/metabolismo , Microscopía Confocal , Nanopartículas/química , Oxazinas , Piperazinas , PiridonasRESUMEN
BACKGROUND: Intrinsic iron in biological tissues frequently precludes unambiguous the identification of iron oxide nanoparticles when iron-based detection methods are used. Here we report the full methodology for synthesizing very small iron oxide nanoparticles (VSOP) doped with europium (Eu) in their iron oxide core (Eu-VSOP) and their unambiguous qualitative and quantitative detection by fluorescence. METHODS AND RESULTS: The resulting Eu-VSOP contained 0.7 to 2.7% Eu relative to iron, which was sufficient for fluorescent detection while not altering other important particle parameters such as size, surface charge, or relaxivity. A customized enhancer solution with high buffer capacity and nearly neutral pH was developed to provide an antenna system that allowed fluorescent detection of Eu-VSOP in cells and histologic tissue slices as well as in solutions even under acidic conditions as frequently obtained from dissolved organic material. This enhancer solution allowed detection of Eu-VSOP using a standard fluorescence spectrophotometer and a fluorescence microscope equipped with a custom filter set with an excitation wavelength (λex) of 338 nm and an emission wavelength (λem) of 616 nm. CONCLUSION: The fluorescent detection of Eu-doped very small iron oxide nanoparticles (Eu-VSOP) provides a straightforward tool to unambiguously characterize VSOP biodistribution and toxicology at tissue, and cellular levels, providing a sensitive analytical tool to detect Eu-doped IONP in dissolved organ tissue and biological fluids with fluorescence instruments.
Asunto(s)
Europio/análisis , Compuestos Férricos/análisis , Nanopartículas/análisis , Animales , Europio/farmacocinética , Compuestos Férricos/síntesis química , Compuestos Férricos/farmacocinética , Ratones , Ratones Endogámicos C57BL , Microscopía Fluorescente/métodos , Nanopartículas/ultraestructura , Nanotecnología/métodos , Células RAW 264.7 , Distribución TisularRESUMEN
Despite advances in cancer therapy, treating cancer after it has metastasized remains an unmet clinical challenge. In this study we demonstrate that 100 nm liposomes target triple-negative murine breast-cancer metastases post intravenous administration. Metastatic breast cancer was induced in BALB/c mice either experimentally, by a tail vein injection of 4T1 cells, or spontaneously, after implanting a primary tumor xenograft. To track their biodistribution in vivo the liposomes were labeled with multi-modal diagnostic agents, including indocyanine green and rhodamine for whole-animal fluorescent imaging, gadolinium for magnetic resonance imaging (MRI), and europium for a quantitative biodistribution analysis. The accumulation of liposomes in the metastases peaked at 24 h post the intravenous administration, similar to the time they peaked in the primary tumor. The efficiency of liposomal targeting to the metastatic tissue exceeded that of a non-liposomal agent by 4.5-fold. Liposomes were detected at very early stages in the metastatic progression, including metastatic lesions smaller than 2 mm in diameter. Surprisingly, while nanoparticles target breast cancer metastasis, they may also be found in elevated levels in the pre-metastatic niche, several days before metastases are visualized by MRI or histologically in the tissue. This study highlights the promise of diagnostic and therapeutic nanoparticles for treating metastatic cancer, possibly even for preventing the onset of the metastatic dissemination by targeting the pre-metastatic niche.
Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Sistemas de Liberación de Medicamentos/métodos , Liposomas/farmacocinética , Neoplasias Pulmonares/diagnóstico por imagen , Metástasis de la Neoplasia/diagnóstico por imagen , Neoplasias de la Mama Triple Negativas/diagnóstico por imagen , Animales , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/secundario , Línea Celular Tumoral , Europio/química , Europio/farmacocinética , Femenino , Humanos , Verde de Indocianina/química , Verde de Indocianina/farmacocinética , Liposomas/síntesis química , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/secundario , Imagen por Resonancia Magnética , Ratones , Ratones Endogámicos BALB C , Nanopartículas/química , Metástasis de la Neoplasia/patología , Trasplante de Neoplasias , Imagen Óptica , Rodaminas/química , Rodaminas/farmacocinética , Distribución Tisular , Neoplasias de la Mama Triple Negativas/metabolismo , Neoplasias de la Mama Triple Negativas/secundarioRESUMEN
This work presents the synthesis by coprecipitation of diamond shaped Yb:Er:NaGd(WO4)2 crystalline nanoparticles (NPs) with diagonal dimensions in the 5-7 nm × 10-12 nm range which have been modified with TWEEN80 for their dispersion in water, and their interaction with mesenchymal stem cells (MSCs) proposed as cellular NP vehicles. These NPs belong to a large family of tetragonal Yb:Er:NaT(XO4)2 (T = Y, La, Gd, Lu; X = Mo, W) compounds with green (2H11/2 + 4S3/2 â 4I15/2) Er-related upconversion (UC) efficiency comparable to that of Yb:Er:ß-NaYF4 reference compound, but with a ratiometric thermal sensitivity (S) 2.5-3.5 times larger than that of the fluoride. At the temperature range of interest for biomedical applications (â¼293-317 K/20-44 °C) S = 108-118 × 10-4 K-1 for 20 at%Yb:5 at%Er:NaGd(WO4)2 NPs, being the largest values so far reported using the 2H11/2/4S3/2 Er intensity ratiometric method. Cultured MSCs, incubated with these water NP emulsions, internalize and accumulate the NPs enclosed in endosomes/lysosomes. Incubations with up to 10 µg of NPs per ml of culture medium maintain cellular metabolism at 72 h. A thermal assisted excitation path is discussed as responsible for the UC behavior of Yb:Er:NaT(XO4)2 compounds.
Asunto(s)
Europio , Gadolinio , Calor , Células Madre Mesenquimatosas/metabolismo , Nanopartículas , Polisorbatos , Compuestos de Tungsteno , Iterbio , Endosomas/metabolismo , Europio/química , Europio/farmacocinética , Europio/farmacología , Gadolinio/química , Gadolinio/farmacocinética , Gadolinio/farmacología , Humanos , Lisosomas/metabolismo , Células Madre Mesenquimatosas/citología , Nanopartículas/química , Nanopartículas/uso terapéutico , Polisorbatos/química , Polisorbatos/farmacocinética , Polisorbatos/farmacología , Compuestos de Tungsteno/química , Compuestos de Tungsteno/farmacocinética , Compuestos de Tungsteno/farmacología , Iterbio/química , Iterbio/farmacocinética , Iterbio/farmacologíaRESUMEN
Biodegradable zinc oxide nanoparticles (ZnO NPs) are considered promising materials for future biomedical applications. To fulfil this potential, biodistribution and elimination patterns of ZnO NPs in the living organism need to be resolved. In order to investigate gastrointestinal absorption of ZnO NPs and their intra-organism distribution, water suspension of ZnO or fluorescent ZnO:Eu (Europium-doped zinc oxide) NPs (10mg/ml; 0.3ml/mouse) was alimentary-administered (IG: intra-gastric) to adult mice. Internal organs collected at key time-points after IG were evaluated by AAS for Zn concentration and analysed by cytometric techniques. We found that Zn-based NPs were readily absorbed and distributed (3 h post IG) in the nanoparticle form throughout the organism. Results suggest, that liver and kidneys were key organs responsible for NPs elimination, while accumulation was observed in the spleen and adipose tissues. We also showed that ZnO/ZnO:Eu NPs were able to cross majority of biological barriers in the organism (including blood-brain-barrier).
Asunto(s)
Europio/metabolismo , Europio/farmacocinética , Nanopartículas/análisis , Nanopartículas/metabolismo , Óxido de Zinc/metabolismo , Óxido de Zinc/farmacocinética , Animales , Barrera Hematoencefálica/metabolismo , Sistema Digestivo/metabolismo , Europio/administración & dosificación , Colorantes Fluorescentes/administración & dosificación , Colorantes Fluorescentes/metabolismo , Colorantes Fluorescentes/farmacocinética , Absorción Gastrointestinal , Riñón/metabolismo , Hígado/metabolismo , Ratones , Ratones Endogámicos BALB C , Nanopartículas/administración & dosificación , Nanopartículas/ultraestructura , Distribución Tisular , Óxido de Zinc/administración & dosificaciónRESUMEN
Eu(II) -based contrast agents offer physiologically relevant, metal-based redox sensing that is unachievable with Gd(III) -based contrast agents. To evaluate the in vivo contrast enhancement of Eu(II) as a function of injection type, we performed intravenous, intraperitoneal, and subcutaneous injections in mice. Our data reveal a correlation between reported oxygen content and expected rates of diffusion with the persistence of Eu(II) -based contrast enhancement. Biodistribution studies revealed europium clearance through the liver and kidneys for intravenous and intraperitoneal injections, but no contrast enhancement was observed in organs associated with clearance. These data represent a step toward understanding the behavior of Eu(II) -based complexes in vivo. Copyright © 2016 John Wiley & Sons, Ltd.
Asunto(s)
Medios de Contraste/farmacocinética , Europio/farmacocinética , Inyecciones/métodos , Animales , Medios de Contraste/administración & dosificación , Medios de Contraste/análisis , Europio/análisis , Inyecciones Intraperitoneales , Inyecciones Intravenosas , Inyecciones Subcutáneas , Riñón/metabolismo , Hígado/metabolismo , Tasa de Depuración Metabólica , Ratones , Distribución TisularRESUMEN
Nanoscaled europium oxide (Eu2O3) particles were inhaled by rats after acute exposure and the potential translocation of particles followed by chemical analysis and transmission electron microscopy (TEM) was investigated. An aqueous dispersion (phosphate buffer/bovine serum albumin) of a commercially available Eu2O3 particle fraction consisting partially of nanoscaled particles was aerosolized with pressurized air. After rapid evaporation, rats inhaled the dry aerosol for 6 h in a single exposure resulting in an alveolar calculated dose of approximately 39.5 µg Eu2O3. Using chemical analysis, 36.8 µg Eu2O3 was detected 1 h after lung inhalation. The amount declined slightly to 34.5 µg after 1 day and 35.0 µg after 5 days. The liver showed an increase of Eu2O3 from 32.3 ng 1 h up to 294 ng 5 days after inhalation. Additionally, lung-associated lymph nodes, thymus, kidneys, heart and testis exhibited an increase of europium over the period investigated. In the blood, the highest amount of europium was found 1 h after treatment whereas feces, urine and mesenteric lymph nodes revealed the highest amount 1 day after treatment. Using TEM analysis, particles could be detected only in lungs, and in the liver, no particles were detectable. In conclusion, the translocation of Eu2O3 within 5 days following inhalation could be determined very precisely by chemical analysis. A translocation of Eu2O3 particulate matter to liver was not detectable by TEM analysis; thus, the overproportional level of 0.8% of the lung load observed in the liver after 5 days suggests a filtering effect of dissolved europium with accumulation.
Asunto(s)
Europio/administración & dosificación , Europio/farmacocinética , Hígado/metabolismo , Pulmón/metabolismo , Nanopartículas del Metal/administración & dosificación , Óxidos/administración & dosificación , Óxidos/farmacocinética , Absorción a través del Sistema Respiratorio , Administración por Inhalación , Aerosoles , Animales , Europio/sangre , Europio/química , Estudios de Factibilidad , Pulmón/ultraestructura , Masculino , Nanopartículas del Metal/química , Microscopía Electrónica de Transmisión , Óxidos/química , Ratas Wistar , Solubilidad , Espectrometría por Rayos X , Distribución TisularRESUMEN
The fate of radionuclides in the environment is a cause of great concern for modern society, seen especially in 2011 after the Fukushima accident. Among the environmental compartments, seawater covers most of the earth's surface and may be directly or indirectly impacted. The interaction between radionuclides and the marine compartment is therefore essential for better understanding the transfer mechanisms from the hydrosphere to the biosphere. This information allows for the evaluation of the impact on humans via our interaction with the biotope that has been largely undocumented up to now. In this report, we attempt to make a link between the speciation of heavy elements in natural seawater and their uptake by a model marine organism. More specifically, because the interaction of actinides with marine invertebrates has been poorly studied, the accumulation in a representative member of the Mediterranean coralligenous habitat, the sponge Aplysina cavernicola, was investigated and its uptake curve exposed to a radiotracer (241)Am was estimated using a high-purity Ge gamma spectrometer. But in order to go beyond the phenomenological accumulation rate, the speciation of americium(III) in seawater must be assessed. The speciation of (241)Am (and natural europium as its chemically stable surrogate) in seawater was determined using a combination of different techniques: Time-Resolved Laser-Induced Fluorescence (TRLIF), Extended X-ray Absorption Fine Structure (EXAFS) at the LIII edge, Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) spectroscopy and Scanning Electron Microscopy (SEM) and the resulting data were compared with the speciation modeling. In seawater, the americium(III) complex (as well as the corresponding europium complex, although with conformational differences) was identified as a ternary sodium biscarbonato complex, whose formula can be tentatively written as NaAm(CO3)2·nH2O. It is therefore this chemical form of americium that is accumulated by the sponge A. cavernicola.
Asunto(s)
Americio/química , Americio/farmacocinética , Poríferos/metabolismo , Agua de Mar/química , Contaminantes Radiactivos del Agua/química , Contaminantes Radiactivos del Agua/farmacocinética , Animales , Europio/química , Europio/farmacocinéticaRESUMEN
Soluble Amyloid-beta (Aß) oligomers are a source of cytotoxicity in Alzheimer's disease (AD). The toxicity of Aß oligomers may arise from their ability to interact with and disrupt cellular membranes mediated by GM1 ganglioside receptors within these membranes. Therefore, inhibition of Aß-membrane interactions could provide a means of preventing the toxicity associated with Aß. Here, using Surface Plasmon field-enhanced Fluorescence Spectroscopy, we determine that the lanthanide, Europium III chloride (Eu(3+)), strongly binds to GM1 ganglioside-containing membranes and prevents the interaction with Aß42 leading to a loss of the peptides ability to cause membrane permeation. Here we discuss the molecular mechanism by which Eu(3+) inhibits Aß42-membrane interactions and this may lead to protection of membrane integrity against Aß42 induced toxicity.
Asunto(s)
Péptidos beta-Amiloides/antagonistas & inhibidores , Permeabilidad de la Membrana Celular/efectos de los fármacos , Europio/farmacocinética , Europio/farmacología , Gangliósido G(M1)/metabolismo , Membrana Dobles de Lípidos/química , Espectrometría de Fluorescencia , Resonancia por Plasmón de SuperficieRESUMEN
On the assumption that rare earth elements (REEs) are nontoxic, they are being utilized as replacements of toxic heavy metals in novel technological applications. However, REEs are not entirely innocuous, and their impact on health is still uncertain. In the past decade, our laboratory has studied the urinary excretion of REEs in male Wistar rats given chlorides of europium, scandium, and yttrium solutions by one-shot intraperitoneal injection or oral dose. The present paper describes three experiments for the suitability and appropriateness of a method to use urine for biological monitoring of exposure to these REEs. The concentrations of REEs were determined in cumulative urine samples taken at 0-24 h by inductively coupled plasma atomic emission spectroscopy, showing that the urinary excretion of REEs is <2 %. Rare earth elements form colloidal conjugates in the bloodstream, which make high REEs accumulation in the reticuloendothelial system and glomeruli and low urinary excretion. The high sensitivity of inductively coupled plasma-argon emission spectrometry analytical methods, with detection limits of <2 µg/L, makes urine a comprehensive assessment tool that reflects REE exposure. The analytical method and animal experimental model described in this study will be of great importance and encourage further discussion for future studies.
Asunto(s)
Monitoreo del Ambiente/métodos , Contaminantes Ambientales/orina , Europio/orina , Escandio/orina , Itrio/orina , Administración Oral , Animales , Cloruros/administración & dosificación , Relación Dosis-Respuesta a Droga , Exposición a Riesgos Ambientales/efectos adversos , Contaminantes Ambientales/farmacocinética , Contaminantes Ambientales/toxicidad , Europio/administración & dosificación , Europio/farmacocinética , Europio/toxicidad , Inyecciones Intraperitoneales , Límite de Detección , Masculino , Tasa de Depuración Metabólica , Ratas , Ratas Wistar , Reproducibilidad de los Resultados , Escandio/administración & dosificación , Escandio/farmacocinética , Escandio/toxicidad , Espectrofotometría Atómica , Itrio/administración & dosificación , Itrio/farmacocinética , Itrio/toxicidadRESUMEN
We present a facile synthesis of europium-doped gadolinium sulfide (GdS:Eu(3+)) opto-magnetic nanoparticles (NPs) via sonochemistry. Their photoluminescence and strong paramagnetic properties enable these NPs to be utilized as an in vitro cell imaging and in vivo T(1)-weighted MR imaging probe. The GdS:Eu(3+) NPs have a prominent longitudinal (r(1)) relaxivity value, which is a critical parameter for T(1)-weighted MR imaging. Here, we showed not only their strong positive contrast effect to blood vessels and organs of mice, but also blood half-life and biodistribution including clearance from organs, in order to assess the GdS:Eu(3+) NPs as a competent nanocrystal-based T(1) contrast agent. We further showed confocal images of breast cancer cells containing GdS:Eu(3+) NPs to evaluate as a photoluminescence probe. Dual-mode imaging capability obtained from the GdS:Eu(3+) NPs will allow target-oriented cellular imaging as well as the resulting disease-specific MR imaging.
Asunto(s)
Neoplasias de la Mama/diagnóstico , Medios de Contraste , Europio , Gadolinio , Mediciones Luminiscentes/métodos , Imagen por Resonancia Magnética/métodos , Nanopartículas , Animales , Mama/patología , Neoplasias de la Mama/patología , Línea Celular Tumoral , Medios de Contraste/química , Medios de Contraste/farmacocinética , Europio/química , Europio/farmacocinética , Femenino , Gadolinio/química , Gadolinio/farmacocinética , Semivida , Humanos , Ratones , Ratones Endogámicos BALB C , Microscopía Confocal/métodos , Nanopartículas/química , Sulfuros/química , Sulfuros/farmacocinéticaRESUMEN
Exchange of water molecules between the frequency-shifted inner-sphere of a paramagnetic lanthanide ion and aqueous solvent can shorten the T(2) of bulk water protons. The magnitude of the line-broadening T(2) exchange (T(2exch)) is determined by the lanthanide concentration, the chemical shift of the exchanging water molecule, and the rate of water exchange between the two pools. A large T(2exch) contribution to the water linewidth was initially observed in experiments involving Eu(3+)-based paramagnetic chemical exchange saturation transfer agents in vivo at 9.4 T. Further in vitro and in vivo experiments using six different Eu(3+) complexes having water exchange rates ranging from zero (no exchange) to 5 × 10(6) s(-1) (fast exchange) were performed. The results showed that the exchange relaxivity (r(2exch)) is small for complexes having either very fast or very slow exchange, but reaches a well-defined maximum for complexes with intermediate water exchange rates. These experimental results were verified by Bloch simulations for two site exchange. This new class of T(2exch) agent could prove useful in the design of responsive MRI contrast agents for molecular imaging of biological processes.
Asunto(s)
Agua Corporal/metabolismo , Medios de Contraste/farmacocinética , Europio/farmacocinética , Riñón/anatomía & histología , Riñón/metabolismo , Imagen por Resonancia Magnética/métodos , Animales , Medios de Contraste/clasificación , Femenino , Aumento de la Imagen/métodos , Ratones , Reproducibilidad de los Resultados , Sensibilidad y EspecificidadRESUMEN
Single doses of europium (III) chloride hexahydrate were orally administered to several groups of rats. Cumulative urine samples were taken at 0-24 h, and blood samples were drawn after 24-h administration. The europium concentration was determined in these samples by inductively coupled plasma atomic emission spectroscopy. The volume, creatinine, ß-2-microglobulin, and N-acetyl-ß-D-glucosaminidase were measured in the urine samples to evaluate possible europium-induced renal effects. The blood samples showed low europium distribution, with an average of 77.5 µg/L for all groups. Although the urinary concentration and excretion showed dose-dependent increases, the percentage of europium excreted showed a dose-dependent decrease, with an average of 0.31% in all groups. The administration of europium resulted in a significant decrease of creatinine and a significant increase of urinary volume, N-acetyl-ß-D-glucosaminidase, and ß-2-microglobulin. Rare earth elements, including europium, are believed to form colloidal conjugates that deposit in the reticuloendothelial system and glomeruli. This specific reaction may contribute to low europium bioavailability and renal function disturbances. Despite low bioavailability, the high performance of the analytical method for determination of europium makes the blood and urine sampling suitable tools for monitoring of exposure to this element. The results presented in this study will be of great importance in future studies on the health impacts of rare earth elements.
Asunto(s)
Europio/farmacología , Europio/farmacocinética , Riñón/efectos de los fármacos , Riñón/metabolismo , Acetilglucosaminidasa/metabolismo , Animales , Creatinina/metabolismo , Europio/sangre , Europio/orina , Masculino , Ratas , Ratas Wistar , Espectrofotometría Atómica , Microglobulina beta-2/metabolismoRESUMEN
In this article, a single-label separation-free fluorescence technique is presented as a potential screening method for cell-based receptor antagonists and agonists.The time-resolved fluorescence technique, quenching resonance energy transfer (QRET), relies on a single-labeled binding partner in combination with a soluble quencher. The quencher efficiently suppresses the luminescence of the unbound labeled ligand, whereas the luminescence of the bound fraction is not affected. This approach allows the development of cell-based screening assays in a simple and cost-effective manner. The authors have applied the technique to the screening of beta(2)-adrenoreceptor (beta(2)AR) antagonists and agonists in intact human embryonic kidney HEK293(i) cells overexpressing human beta(2)-adrenergic receptors. Two antagonists (propranolol, alprenolol) and 2 agonists (metaproterenol, terbutaline) for beta(2)AR were investigated in a displacement assay using europium(III)-labeled pindolol ligand. The assay Z' values ranged from 0.68 to 0.78, the coefficient of variation was less than 10%, and the K(i) values were 19 nM for propranolol and alprenolol and 14 and 5.9 microM for metaproterenol and terbutaline, respectively. The QRET technique with beta(2)AR was also applied to LOPAC compound library screening, yielding nearly error-free recognition of known binders. This simple and cost-effective technique can be readily adapted to laboratory and industrial-scale screening.
Asunto(s)
Evaluación Preclínica de Medicamentos/métodos , Transferencia Resonante de Energía de Fluorescencia/métodos , Ligandos , Receptores de Superficie Celular/metabolismo , Agonistas de Receptores Adrenérgicos beta 2 , Antagonistas de Receptores Adrenérgicos beta 2 , Agonistas Adrenérgicos beta/aislamiento & purificación , Agonistas Adrenérgicos beta/farmacocinética , Antagonistas Adrenérgicos beta/aislamiento & purificación , Antagonistas Adrenérgicos beta/farmacocinética , Alprenolol/farmacocinética , Células Cultivadas , Europio/farmacocinética , Humanos , Mediciones Luminiscentes , Metaproterenol/farmacocinética , Modelos Biológicos , Propranolol/farmacocinética , Unión Proteica , Terbutalina/farmacocinéticaRESUMEN
The accumulation of samarium from a solution only containing samarium by Arthrobacter nicotianae was examined. The amount of accumulated samarium was strongly affected by the concentration of samarium and pH of the solution. The accumulation of samarium by the strain was very rapid and reached equilibrium within 3h. The accumulation of samarium-europium or europium-gadolinium from the solution containing the two metals using various actinomycetes and gram-positive bacteria was also examined. Most of the tested strains could accumulate similar amounts of samarium and europium; however, most of the tested strains could accumulate a greater amount of europium than gadolinium. Especially, the amounts of accumulated europium using gram-positive bacteria were higher than those using actinomycetes. The selective accumulations of light or heavy rare earth elements (REEs) using A. nicotianae and Streptomyces albus were also examined. The amounts of accumulated samarium and europium were higher than those of the other light REEs using both microorganisms. S. albus can accumulate greater lutetium than other REEs from a solution containing yttrium and eight heavy REEs. On the other hand, A. nicotianae can accumulate higher amounts of terbium and ytterbium than that of the other heavy REEs from the same solution. A. nicotianae can also accumulated higher amounts of Sm than other REEs from a solution containing six light REEs.
Asunto(s)
Bacterias Grampositivas/metabolismo , Metales de Tierras Raras/farmacocinética , Arthrobacter/metabolismo , Transporte Biológico Activo , Europio/farmacocinética , Gadolinio/farmacocinética , Concentración de Iones de Hidrógeno , Metales Pesados/farmacocinética , Metales Ligeros/farmacocinética , Samario/farmacocinética , Soluciones , Streptomyces/metabolismo , Itrio/farmacocinéticaRESUMEN
A europium complex selectively staining the nucleolus of NIH 3T3, HeLa, and HDF cells is reported. This complex possesses not only the advantage of the long lifetime of europium emission (0.3 ms), but also a chromophore that allows excitation at a relatively long wavelength (lambda(max) = 384 nm) and gives rise to an acceptable quantum yield (9%). The complex can be used both in live cell and fixed cell imaging, giving an average intracellular concentration on the order of 0.5 microM. Strong binding to serum albumin has been demonstrated by examination of the analogous gadolinium complex, studying relaxivity changes with increasing protein concentration. The intracellular speciation of the complex has been examined by circularly polarized emission spectroscopy and is consistent with the presence of more than one europium species, possibly protein bound.
Asunto(s)
Nucléolo Celular/química , Nucléolo Celular/metabolismo , Europio/química , Europio/farmacocinética , Compuestos Organometálicos/química , Compuestos Organometálicos/farmacocinética , Animales , Ciclamas , Europio/metabolismo , Compuestos Heterocíclicos/química , Humanos , Mediciones Luminiscentes/métodos , Ratones , Células 3T3 NIH , Compuestos Organometálicos/metabolismo , Coloración y Etiquetado/métodos , Tioxantenos/química , Xantonas/químicaRESUMEN
2-[4-(3,4-Dimethylphenlyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393) was identified as a potent dopamine D4 receptor antagonist with excellent receptor selectivity. [3H]-spiperone competition binding assays showed that A-381393 potently bound to membrane from cells expressing recombinant human dopamine D4.4 receptor (Ki=1.5 nM), which was 20-fold higher than that of clozapine (Ki=30.4 nM). A-381393 exhibited highly selective binding for the dopamine D4.4 receptor (>2700-fold) when compared to D1, D2, D3 and D5 dopamine receptors. Furthermore, in comparison to clozapine and L-745870, A-381393 exhibits better receptor selectivity, showing no affinity up to 10 microM for a panel of more than 70 receptors and channels, with the exception of moderate affinity for 5-HT2A (Ki=370 nM). A-381393 potently inhibited the functional activity of agonist-induced GTP-gamma-S binding assay and 1 microM dopamine induced-Ca2+ flux in human dopamine D4.4 receptor expressing cells, but not in human dopamine D2L or D3 receptor cells. In contrast to L-745870, A-381393 did not exhibit any significant intrinsic activity in a D4.4 receptor. In vivo, A-381393 has good brain penetration after subcutaneous administration. A-381393 inhibited penile erection induced by the selective D4 agonist PD168077 in conscious rats. Thus, A-381393 is a novel selective D4 antagonist that will enhance the ability to study dopamine D4 receptors both in vitro and in vivo.
Asunto(s)
Antagonistas de Dopamina/síntesis química , Antagonistas de Dopamina/farmacología , Animales , Benzamidas/farmacología , Bencimidazoles/síntesis química , Bencimidazoles/farmacocinética , Bencimidazoles/farmacología , Unión Competitiva/efectos de los fármacos , Calcio/metabolismo , Línea Celular , Clozapina/farmacocinética , Dopamina/metabolismo , Antagonistas de Dopamina/química , Relación Dosis-Respuesta a Droga , Vías de Administración de Medicamentos , Interacciones Farmacológicas , Europio/farmacocinética , Fluorometría/métodos , Antagonistas del GABA/farmacocinética , Guanosina Trifosfato/farmacocinética , Humanos , Masculino , Erección Peniana/efectos de los fármacos , Piperazinas/síntesis química , Piperazinas/farmacocinética , Piperazinas/farmacología , Piridinas/farmacocinética , Pirroles/farmacocinética , Ensayo de Unión Radioligante/métodos , Ratas , Ratas Sprague-Dawley , Ratas Wistar , Espiperona/farmacocinética , Factores de Tiempo , Tritio/farmacocinéticaRESUMEN
The uptake of Eu3+ by elongating oat roots was studied by fluorescence spectroscopy, fluorescence lifetime measurement, and a laser excitation time-resolved confocal fluorescence profiling technique. The results of this work indicated that initial uptake of Eu3+ was highest within the undifferentiated cells of the root tip just behind the root cap, a region of maximal cell growth and differentiation and with incomplete formation of the Casparian strip around the central vascular cylinder. Distribution of assimilated Eu3+ within the root's differentiation and elongation zone was nonuniform. Higher concentrations of Eu3+ were observed within the vascular cylinder, specifically in the phloem and developing xylem parenchyma. Elevated levels of the metal were also observed in the root hairs of the mature root zone. Fluorescence spectroscopic characteristics of the assimilated Eu3+ suggested that the Eu3+ exists as inner-sphere mononuclear complexes inside the root. This work also demonstrated the effectiveness of a time-resolved Eu3+ fluorescence spectroscopy and confocal fluorescence profiling techniques for the in vivo, real-time study of metal [Eu3+] accumulation by a functioning intact plant root. This approach can prove valuable for basic and applied studies in plant nutrition and environmental uptake of actinide radionuclides.